Pneuma

Pneuma Behavioral Health Bolsters Executive Team With Appointment of Chief Growth Officer

Retrieved on: 
Wednesday, September 13, 2023
Mental Health, Health, Consumer, Women, Teens, General Health, Men, Pneuma, Mental health, Acquisition, Mental, CGO, Management

Pneuma Behavioral Health (“Pneuma”), a leading provider of comprehensive mental health services across North Carolina, proudly announces the appointment of Tammy George as its new Chief Growth Officer (CGO).

Key Points: 
  • Pneuma Behavioral Health (“Pneuma”), a leading provider of comprehensive mental health services across North Carolina, proudly announces the appointment of Tammy George as its new Chief Growth Officer (CGO).
  • With nearly three decades of experience in the healthcare industry, Ms. George brings a proven track record of driving revenue growth and optimizing profitability.
  • "At a time when Pneuma is accelerating at such a rapid pace, we are thrilled to welcome Tammy George as our CGO," said Albert Lupin, Founder and CEO of Pneuma Behavioral Health.
  • In her senior leadership role, Ms. George will assemble and lead a high-performing team dedicated to executing growth strategies and operational improvements.

Pneuma Behavioral Health Expands Reach with Acquisition of Adolescent Outpatient Mental Health Treatment Center in Wake Forest

Retrieved on: 
Wednesday, August 9, 2023
General Health, Mental Health, Consumer, Health, Teens, Heart, Partnership, Accreditation, CARF, Education, Hospital, Aetna, Parent, Blue Cross Blue Shield Association, Mental health, Commission on Accreditation of Rehabilitation Facilities, Cigna, School, Student, Acquisition, Wake Forest, Mental, Jim Thorpe, Interior design, Road, Pneuma

Pneuma Behavioral Health (“Pneuma”) is pleased to announce its strategic acquisition of Bright Path Behavioral Health (“Bright Path”).

Key Points: 
  • Pneuma Behavioral Health (“Pneuma”) is pleased to announce its strategic acquisition of Bright Path Behavioral Health (“Bright Path”).
  • Located in the heart of Wake Forest, Bright Path stands as the greater Triangle’s only CARF-Accredited, in-network partial hospitalization and intensive outpatient treatment center specifically for adolescents ages 13 to 18.
  • This acquisition marks a significant milestone in Pneuma’s journey, reinforcing its stature as a premier provider of comprehensive mental health services throughout North Carolina.
  • Albert Lupin, Founder of Pneuma Behavioral Health, expressed his enthusiasm: “We’re excited to welcome Bright Path into the Pneuma family.

Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products

Retrieved on: 
Thursday, February 2, 2023
Research, Pharmaceutical, Hardware, Tobacco, Apps, Applications, Medical Devices, Technology, Retail, Clinical Trials, Science, FDA, Health, Aerosol, Smoking, Respiratory system, Faculty, Pneuma, Patient, Smoking cessation, Merck Consumer Health, COPD, Nicotine, Physics, Carcinogen, Foxconn, Multimedia, Pharmaceutical industry

Pneuma’s platform will, for the first time, provide a means to use nonheated aerosols for inhaled nicotine smoking cessation treatments and has the potential for a major impact on the reduced-risk nicotine consumer market.

Key Points: 
  • Pneuma’s platform will, for the first time, provide a means to use nonheated aerosols for inhaled nicotine smoking cessation treatments and has the potential for a major impact on the reduced-risk nicotine consumer market.
  • (Photo: Business Wire)
    Pneuma has a joint development program with a leading tobacco company aimed at creating nonheated nicotine delivery products.
  • Pneuma’s digital platform is designed to precisely deliver nicotine to satisfy cravings and dynamically step down the amount over time.
  • In addition to smoking cessation and reduced-risk nicotine, Pneuma’s programs target COPD and other lung conditions.

Pneuma Respiratory Shares Improvements to Digital Soft Mist Inhaler at J.P Morgan Healthcare Conference

Retrieved on: 
Monday, January 9, 2023
General Health, Health Technology, Health, Medical Devices, Conference, Respiratory system, Therapy, Pneuma, Human, Pharmaceutical industry

Pneuma Respiratory, a healthcare company focused on the advancement of inhaled respiratory therapeutics, is attending this week’s 41st Annual J.P. Morgan Healthcare Conference in San Francisco to unveil the latest iteration of its fully digital soft mist inhaler.

Key Points: 
  • Pneuma Respiratory, a healthcare company focused on the advancement of inhaled respiratory therapeutics, is attending this week’s 41st Annual J.P. Morgan Healthcare Conference in San Francisco to unveil the latest iteration of its fully digital soft mist inhaler.
  • First introduced in 2018, Pneuma Respiratory’s soft mist technology uses electronic breath actuation to simplify usage and improve delivery efficiency.
  • The digital component delivers high dose confidence and real-time dosage verification to healthcare providers.
  • “With our recent innovations we are seeing real progress in establishing partnerships that will directly impact patient outcomes,” said Eric Hunter, Pneuma Respiratory CEO.

Pneuma Systems Names Dr. Roxie Mooney, Global Leader in Healthcare Innovation Strategy, as Director

Retrieved on: 
Tuesday, November 8, 2022
DBA, Business administration, IV, Workflow, Amazon, Walden University, Industry, Patient, Board, Nursing, West Pharmaceutical Services, Doctor of Philosophy, Harvard Business School, Board of directors, Science, Multimedia, CEO, Medical device, Management, Pneuma

PORTSMOUTH, N.H., Nov. 8, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced the appointment of Roxie Mooney, DBA to its Board of Directors. The company is appointing Dr. Mooney as it commercializes infusion innovations in a $20-billion infusion therapy market forecast to top $31 billion by 2030[1]. Pneuma is launching innovative solutions that will provide a seamless continuum of care for patients facing a complex array of infusion therapies.

Key Points: 
  • PORTSMOUTH, N.H., Nov. 8, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced the appointment of Roxie Mooney, DBA to its Board of Directors.
  • Pneuma is launching innovative solutions that will provide a seamless continuum of care for patients facing a complex array of infusion therapies.
  • "Pneuma is truly disrupting the healthcare status quo, making infusion care easier and safer for patients and nurses."
  • "We need an experienced guide as we introduce unprecedented innovation to one of the most important and prevalent procedures in healthcare.

Pneuma Systems names recognized thought leader in reliability to exploit the company's novel "self-aware" infusion system

Retrieved on: 
Monday, August 8, 2022
Multimedia, ASQ, Industry, IV, Growth, Center, Engineering, Mechanical engineering, Suggestion, Program, Partnership, Workflow, Pharmacotherapy, Infusion, Medical device, Pharmaceutical industry, Pneuma, Northeastern University

PORTSMOUTH, N.H., Aug. 8, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced a new partnership with Apex Ridge Consulting (www.apexridge.com). Adam Bahret, founder of Apex Ridge, will oversee opportunities for quality improvements in Pneuma's novel fluid flow infusion technology and the development of its pioneering Centers of Infusion Excellence. Pneuma is emerging as a leader in a large and evolving infusion market, which grew by more than 50 percent in 2021 and is estimated to reach $20 billion within the next five years.

Key Points: 
  • PORTSMOUTH, N.H., Aug. 8, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced a new partnership with Apex Ridge Consulting ( www.apexridge.com ).
  • Pneuma is designing for reliability, to create a robust new product right out of the gate.
  • Adam Bahret is a leading expert on reliability as a competitive edge to mitigate risk and drive growth.
  • At Pneuma he will work closely with technical teams to improve product design while fostering a continuous improvement culture.

Connected/Smart Drug Delivery Systems Market worth $7.19 billion by 2028- Exclusive Report by InsightAce Analytic

Retrieved on: 
Thursday, June 30, 2022
Patient, Research, Hospital, COVID-19, Degenerative disease, Industry, Metabolism, Administration, Novo Nordisk, Becton, Dickinson and Company headquarters, Smartphone, US, Metabolic disorder, West Pharmaceutical Services, Merck, CAGR, Solution, Neurological disorder, Diabetes, Recipharm, Acquisition, Clifton Springs Hospital & Clinic, Pneuma, Value, Partnership, Medtronic, Cone Health Women's Hospital, Assessment, BD, Massachusetts Institute of Technology, BWH, Chronic lung disease, Syringe, Respiratory disease, MIT, Alzheimer's disease, No, Sulzer, Pandemic, Asthma, Medical device, Pharmaceutical industry, Brigham

By region, North America dominates the market with major share of global market.

Key Points: 
  • By region, North America dominates the market with major share of global market.
  • Connected/smart drug delivery system uses different approaches, formulations, technologies, and devices to deliver drug to specific sites or target.
  • Connected Smart Drug Delivery Systems help to enhance the therapeutic effect and reduce the related side effects.
  • The cooperation will now last through 2026, with the scope expanded to cover the development and integration of bioelectronics, biosensors, and stimuli-responsive delivery systems.

Pneuma Systems Corporation Recruits Industry Pioneer to Disrupt Home Infusion Space

Retrieved on: 
Monday, June 20, 2022
Industry, Pharmacist, Observation, Friction, Technology, Pharmacotherapy, Said Salim Bakhresa, Caremark, Infusion, Uber, Retirement, Baxter International, Patient, Health, Multimedia, Medical device, Hospital, Pharmaceutical industry, New, Pneuma

PORTSMOUTH N.H., June 20, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced it appointed Stanley N. Chamallas, RPh  FASHP FNHIA, as its Director of Infusion Therapy Process Improvement for Home Care.

Key Points: 
  • PORTSMOUTH N.H., June 20, 2022 /PRNewswire/ --Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced it appointed Stanley N. Chamallas, RPh FASHP FNHIA, as its Director of Infusion Therapy Process Improvement for Home Care.
  • Pneuma Systems Corporation - Transforming Infusion Therapy for patients at home.
  • Mr. Chamallas was one of a handful of pioneering pharmacists that created the now well-established field of home infusion therapy.
  • Pneuma plans to support a network of Centers of Infusion Excellence where therapies are carried out in controlled environments under intense observation.

Pneuma Systems names Chairman of its Scientific Advisory Board

Retrieved on: 
Tuesday, June 7, 2022
Caregiver, C. R. Bard, Company, Intellectual property, Observation, MBA, STEM, Environment, Nursing, Multimedia, Center, Band, Coronavirus Scientific Advisory Board (Turkey), FDA, Patient, Pharmacotherapy, Industry, Engineering, Safety, Pharmaceutical industry, Management, Hospital, Medical device, Pneuma

PORTSMOUTH N.H., June 7, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced that it appointed John Toomey as Chairman of its Scientific Advisory Board.  

Key Points: 
  • PORTSMOUTH N.H., June 7, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the infusion therapy industry, today announced that it appointed John Toomey as Chairman of its Scientific Advisory Board.
  • Empowering Care: Pneuma removes obstacles in infusion therapy, allowing nurses to focus on their patients.
  • Pneuma Founder and CEO Jeffrey Carlisle notes, "John has the ideal background to lead our Scientific Advisory Board and guide the Company with the best strategies for regulatory affairs and intellectual property management.
  • Recently, Pneuma announced a multi-faceted business collaboration with West Pharmaceutical Services, Inc. allowing Pneuma to provide a novel closed-loop fluid flow control platform ( https://prn.to/3Mw8VEX ).

Pneuma Systems names Vice President to develop Centers of Infusion Excellence

Retrieved on: 
Monday, April 25, 2022
Water, West Pharmaceutical Services, Del Wilson Trophy, Workflow, Perseverance, Team leader, Courage, WST, System, J. Emrys Morgan Cup, Caregiver, Leadership, Patient, Engineering, Patient safety, Growth, Technology, Company, LiveRamp, Systems engineering, NYSE, History, Performance, Industry, Multimedia, George Washington University, Pharmacotherapy, Pharmaceutical industry, Medical device, Online shopping, Pneuma, Hinman

PORTSMOUTH, N.H., April 25, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the patient infusion industry with proprietary technology to make the patient experience safe, simpler, and more personalized, today announced that it appointed Miranda Bakos Vice President of Process Transformation.

Key Points: 
  • PORTSMOUTH, N.H., April 25, 2022 /PRNewswire/ -- Pneuma Systems Corporation (Pneuma), an emerging leader in the patient infusion industry with proprietary technology to make the patient experience safe, simpler, and more personalized, today announced that it appointed Miranda Bakos Vice President of Process Transformation.
  • Pneuma will exploit the Company's novel fluid flow technology and lead a collaborative effort to improve every element of infusion therapy.
  • One key piece of this market disruption will be the creation of a network of Centers of Infusion Excellence.
  • Pneuma will collaborate with industry leaders and healthcare providers to measurably improve the process of infusion therapy.